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Open access under CC Ba b s t r a c tProfessor Tomoh Masaki, a Japanese physician-scientist born in 1934, is particularly known for the discovery
of endothelium-derived peptide endothelin and its receptors, among many other scientiﬁc achievements. In
recognition of his work, the Tomoh Masaki Awardwas established in 2011 by the Endothelin International Ad-
visory Board of The International Conferences on Endothelin as a biannual scientiﬁc prize in recognition of
Masaki's innovative and ground-breaking work that has led to new clinical applications. The inaugural
Tomoh Masaki Award was presented at The Twelfth International Conference on Endothelin held in Cambridge,
UK, to one his former graduate students, Professor Masashi Yanagisawa as the ﬁrst recipient of this award,
who played an instrumental role in the discovery of endothelin at the University of Tsukuba, Japan. The arti-
cle summarizes the scientiﬁc achievements of Masaki and the awardee, Masashi Yanagisawa, also including
personal reﬂections of two of Masaki's former graduate students on their teacher as well as on the awardee
of The First Tomoh Masaki Award 2011 and their work as scientists and their role as mentors.
© 2012 Elsevier Inc. Open access under CC BY-NC-ND license.The Tomoh Masaki Award
In early 2011 the Guest Editor proposed to the Endothelin International
Advisory Board to establish a new award in the name of TomohMasaki in
recognition of his innovative and ground-breaking research work in the
ﬁeld of endothelin science and vascular biology which has led to the
development of endothelin receptor antagonists as a new therapeutic
principle in medicine. It was agreed to establish The Tomoh Masaki
Award which was to be presented biannually – after a careful selection
process – on the occasion of the International Conferences on Endothelin
to individuals for their extraordinary contribution in the ﬁeld of
endothelin research in basic or clinical science. The design of the
hand-crafted award plate depicts the amino acid sequence of the
endothelin-1 peptide as well as an artistic impression of Professor
Tomoh Masaki (Fig. 1). This article summarizes the life and work of
Professor Masaki as a scientist and presents the inaugural recipient of
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Y-NC-ND license.who is currently at the University of Texas Southwestern, Dallas, and
the University of Tsukuba, Japan. Also presented are personal reﬂections
of two of Professor Masaki's former graduate students at the Universityof
Tsukuba, Takashi Miyauchi (now Professor of Cardiovascular Medicine at
University of Tsukuba), and Noriaki Emoto (now Professor of Cardiovas-
cular Medicine at Kobe University and Kobe Pharmaceutical University).
Tomoh Masaki: an extraordinary physician-scientist
Born in 1934, Tomoh Masaki obtained his M.D. from the Faculty of
Medicine of the University of Tokyo in the late 1950s and completed
his internship training (Masaki and Sawamura, 2006). In 1963, he
started to work in research at the University of Tokyo with Professor
Setsuro Ebashi (Fig. 2) as a graduate student to eventually obtain a
Ph.D. degree. His work lead to the discovery of α-actinin and
M-protein (Ebashi et al., 1974; Kuroda et al., 1981; Masaki and Takaiti,
1974), as new proteins involved in muscle structural biology. His re-
search also contributed to the identiﬁcation of discovery of other mus-
cular proteins, including different types of myosin and troponin
(Otsuki et al., 1967) as well as describing their role in muscle cell differ-
entiation, which also included identiﬁcation of the gene sequence of
these muscle proteins (Masaki and Sawamura, 2006; Masaki, 2003).
In 1975, Masaki was promoted to Professor of Pharmacology at the
Institute of Basic Medical Sciences at the University of Tsukuba
(Figs. 3 and 4), where most of ground-breaking work was done that
led to the identiﬁcation of endothelin and its ETB receptor in the
late 1980s (Inoue et al., 1989; Sakurai et al., 1990; Yanagisawa et al.,
1988). Professor Masaki moved to the Faculty of Medicine at Kyoto
Fig. 1. The hand-crafted award plate of the Tomoh Masaki Award, showing the amino
acid sequence of the endothelin-1 peptide published in 1988 and an impression of Pro-
fessor Tomoh Masaki. The award was presented to Professor Masashi Yanagisawa at
the Twelfth International Conference on Endothelin in Cambridge, United Kingdom
(Award design by the Guest Editor).
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receptor for oxidized low-density lipoproteins expressed in vascular
endothelial cells (Masaki and Sawamura, 2006; Sawamura et al.,
1997). Following his professorship at Kyoto University, Professor
Masaki was appointed Director of the Research Institute of the
National Cardiovascular Center in Osaka in 1997, and President of
Osaka Seikei University in 2003. In 2007, Masaki was appointed
Professor at Tokyo Women's Medical University from where he re-
tired in 2009. He currently lives in Tokyo, where the Thirteenth
International Conference on Endothelinwill be held in 2013 celebrating
the 25th anniversary of the discovery of endothelin (ET-13 Tokyo).Fig. 2. Three generations of scientiﬁc mentoring: Professors Tomoh Masaki (middle),
Masashi Yanagisawa (right) and Masaki's mentor Setsuro Ebashi (left) with his wife
at the Okazaki National Research Institute, Okazaki, Japan. The photograph was taken
on April 17, 1988 at a time when Ebashi was Professor at the Okazaki National Research
Institute, Japan, just weeks after the report on the discovery of endothelin had been
published in Nature on March 31, 1988.
(Photographs by Hiromi Yanagisawa).Personal reﬂections on a teacher and mentor
In April of 1986, Takashi Miyauchi joined Masaki's laboratory as a
graduate student at the University of Tsukuba. There were two major
projects, one on the molecular analysis of myosin chains (Supervisor
and Head: Professor Masaki), the other on pharmacological charac-
terization of vasoactive peptides (Project Head, Professor Katsutoshi
Goto; Supervisor Professor Masaki; Takashi Miyauchi was part of
this team). After Professor Masaki's team had completed cloning of
smooth muscle myosin heavy chain and sequencing of its cDNA
(Yanagisawa et al., 1987), his laboratory began to work on the identi-
ﬁcation of an endothelium-derived vasoconstricting factor (EDCF) in
May 1987 (Masaki, 1998). Only a few months later, Professor Louis
Ignarro published a paper (Ignarro et al., 1987) identifying NO as
the endothelium-dependent relaxing factor discovered seven years
earlier by Furchgott and Zawadzki (1980).
In early 1987, the cardiology resident Hiroki Kurihara had presented
a paper by Professor Robert Highsmith's group in one of Professor
Masaki's journal clubs describing as a novel endothelial cell-derived
peptidergic vasoconstrictor (Hickey et al., 1985). Graduate student
Masashi Yanagisawa proposed to Professor Masaki to identify this
peptide as his Ph.D. thesis project (Vane, 1991). Yanagisawa and
Kurihara – supervised by Professor Masaki – started their work in May
1987 (Masaki, 1998, 2004). They were joined in their efforts by the
pharmacologist Katsutoshi Goto who supervised and the protein
chemist Sadao Kimura, both were from the Faculty of Basic Medical
Sciences of the University of Tsukuba. Because Professor Masaki's
laboratory had great experience with cloning, molecular biochemistry,
and pharmacology, the works of puriﬁcation, identiﬁcation, and
sequencing cDNA of the EDCF endothelin was completed within seven
months and a manuscript was sent to Nature in December 1987
(Masaki, 1998; Yanagisawa et al., 1988). ProfessorMasaki, being amed-
ical doctor by training, soon developed an interest to study the role of
endothelin in pathophysiology and disease and already before publish-
ing the report in Nature further proposed to explore the role of
endothelin in animal models and patients with cardiovascular disease,
particularly to study changes in endothelin plasma levels.
In January of 1990, Noriaki Emoto joined Professor Masaki's
laboratory as a graduate student. The ﬁrst encounter left a great
impression on Emoto and was important for his own research and
his later life as a scientist. Professor Masaki said:
“Dr. Emoto, there are so many papers published in a year” (spreading
his arms to indicate the amount of publications) “but there are only
a fewmeaningful theses published every year” (showing a half an inch
of a gap with two of his ﬁngers). “Most of them are junk. You should
work on what you believe in, that is important. Never engage in a
meaningless study and waste your time with that.”
Professor Masaki made sure that Emoto could do his research and
provided his support. He did not insist to be informed about every-
thing, arguing that it did not matter so much what everyone was
studying in his laboratory as long as it was unique and interesting.
Professor Masaki's attitude towards research is also evident from
another episode. In February 1992, Professor Masaki's former gradu-
ate student Yanagisawa was about to leave for his new position at
the University of Texas Southwestern Medical School in Dallas, ac-
companied by Emoto, and one day Professor Masaki stopped by the
laboratory and said:
“I really would like to start some new research. We don't have to work
on endothelin anymore since Dr. Yanagisawa is going to be gone soon.
We should start researching something more attractive.”
At a time when the ﬁrst endothelin receptor antagonists were
published, work on the identiﬁcation of endothelin-converting
Fig. 3. Photograph of Professor Tomoh Masaki taken in the summer of 1985 at his lab in
the University of Tsukuba with his student, Yoko Tomobe, ten years after he had joined
the faculty of the University of Tsukuba in 1975.
(Photograph by Yoko-Irukayama Tomobe).
Fig. 5. Photographs of Professor TomohMasaki taken in 1991 at the University of Tsukuba
at the farewell party prior to his transition to the University of Kyoto (left), and taken in
2008 at a celebration with his former students and research fellows (right) after he had
received the First Setsuro Ebashi Award of the Japanese Pharmacological Society for his
contributions to vascular biology.
(Photographs by Yoshitoshi Kasuya and Takashi Miyauchi).
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pathophysiology became unveiled, it seemed that Professor Masaki
had already lost his interest to intensify his studies on endothelin
but rather was looking to start research on something completely
different and new.
The above personal encounters give some reﬂection of Professor
Masaki's attitude as a scientist, mentor, and teacher and his approach
to science. He has been a great mentor to numerous students and
fellows with the ability to pick highly important areas for his research
and is always asking the essential question for science, namely “what
is new?”. He trained, motivated, and encouraged young researches to
think freely and independently, and supported them in their
individual research goals.
Professor Masaki frequently gave parties for his laboratory staff –
sometimes held under cherry blossoms –where he used to sing tradi-
tional Japanese folk songs. Soon after the discovery of endothelin
Professor Masaki became Vice Dean of the University of Tsukuba
Medical School and dedicated much of his time to research and
education of medical students. On December 11, 1990, ProfessorFig. 4. Photograph of Professor Tomoh Masaki in the summer of 1985 at his laboratory
at the University of Tsukuba with his graduate students Yoshitoshi Kasuya, Tomohisa
Ishikawa, and Youichi Miyamoto. These students were involved in two of Professor
Masaki's major projects, one being the molecular analysis of myosin chains, the other
being the pharmacological characterization of vasoactive peptides.
(Photograph by Yoshitoshi Kasuya).Masaki and his colleagues were awarded The Second Tsukuba Prize,
which included a huge silver medal and a research award of ¥ 5 million
(Vane, 1991) which at the time was around 150,000 USD. In 1991,
Professor Masaki moved to the University of Kyoto (Fig. 5).
Masashi Yanagisawa: visionary and researcher
Professor Masashi Yanagisawa is without doubt one of the most
successful scientists among many researchers who studied under
Professor Masaki. His ﬁrst year of graduate school after ﬁnishing
medical school, Yanagisawa spent to learn molecular biological tech-
niques at the National Institute for Physiological Sciences in Okazaki.
This work resulted in his ﬁrst thesis on themolecular structure of myo-
sin (Yanagisawa et al., 1987). For his PhD project he was looking for a
novel (as opposed to an already known molecule), and he convinced
Professor Masaki to identify a peptide that had been described in a re-
cent paper (Hickey et al., 1985) that had been presented and discussed
in the journal club. Professor Masaki accepted this proposal to identify
this peptide and did so by integrating specialists from pharmacology,
protein chemistry, biochemistry, and molecular biology (Masaki,
1998). Being scientiﬁcally highly gifted and dedicated, Yanagisawa, fo-
cusing on his new research project, quickly obtained results and put to-
gether his ﬁrst thesis on endothelin within only in a few months. The
whole project and integrating different disciplines to ensure ultimately
fast results was owed to the oversight and organization of his mentor,
Professor Masaki. At the farewell party at Tsukuba University held for
Professors Masaki and Yanagisawa in 1991, Yanagisawa said that he
was not quite sure if he was deserving to receive accolades from
many of the attendees, but that there was one thing he said he was
proud of, which he put in the following words:
“I made the right decision to choose Professor Masaki as my mentor
among many outstanding professors in Tsukuba University. I chose
to study with Professor Masaki and that was the best choice I could
make. I would not be able to challenge a new task had I not been with
Professor Masaki, and there would have been no discovery of
endothelin and the further progress in endothelin research without
him”.
Following his work on the discovery on endothelin with Professor
Masaki, Professor Yanagisawa continued his research in the
endothelin ﬁeld and made many seminal contributions, including iso-
lation and sequencing of endothelin-2 and endothelin-3, as well as
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of Texas Southwestern Medical School in Dallas in 1992 to set up his
own laboratory where he identiﬁed the two known endothelin
converting enzymes (ECE-1 and ECE-2), and since has fundamentally
contributed to the understanding of the role of endothelin in
physiology and disease by generating animal models using
gene-targeting of components of the endothelin system in speciﬁc
tissues and cells.
The recipient of The First Tomoh Masaki Award (2011)
The inaugural Tomoh Masaki Award (Fig. 1) was presented at The
Twelfth International Conference on Endothelin in Cambridge, UK, in
September 2011 (Barton and Davenport, 2012). Not only in discover-
ing endothelin and contributing key observations to this area of re-
search, Professor Masashi Yanagisawa has been always challenging
new ﬁelds and contributed to the progress in biomedical science and
leaving footsteps with the same scientiﬁc discipline that Professor
Masaki had taught him. Among those nominated, the Endothelin
International Advisory Board unanimously elected Masashi Yanagisawa
as the inaugural recipient of The First Tomoh Masaki Award (2011).
The award was presented to Professor Yanagisawa at the gala dinner
of The Twelfth International Conference on Endothelin at Clare's College
of the University Cambridge (Fig. 6); he was deeply moved about the
recognition he received for his work and for having been chosen as
the inaugural recipient of an award that bears his mentor's name.
When the Tomoh Masaki Award was established in 2011 none of
the members of the Endothelin International Advisory Board was
aware that only a few years before – in 2008 – Professor Masaki
himself had been the recipient of the inaugural Setsuro Ebashi Award
(Masaki, 2008) which the Japanese Pharmacological Society had
created bearing the name of Masaki's mentor Professor Setsuro
Ebashi (Fig. 2), who had died only the year before (Endo, 2006;
Godfraind, 2007; Otsuka, 2007). It comes to no surprise that Professor
Ebashi, who has importantly contributed to the understanding of the
physiological role of intracellular calcium (Endo, 2006; Otsuka, 2007),
had been a good friend of Professor Robert F. Furchgott since the
1960s (Godfraind, 2007). Furchgott was the one who in the late
1970s discovered the importance of endothelial cells as source of va-
soactive factors (Furchgott and Zawadzki, 1980). Ten years earlier,
Professor Ebashi had been awarded the International Prize for Biology
from the Japan Society for the Promotion of Science (1999 International
Prize for Biology) together with the Order of the Sacred Treasure andFig. 6. Professor Masashi Yanagisawa, recipient of The First Tomoh Masaki Award 2011,
during his award speech at the gala dinner of the Twelfth International Conference on
Endothelin held on September 13, 2011 in the Great Hall of Old Court, Clare College,
University of Cambridge.
(Photograph by Suzete Sandin).an Order of Culture from the Emperor and Empress of Japan (1999
International Prize for Biology).
The purpose of The TomohMasaki Awardwill continue to be the rec-
ognition of individuals for their outstanding scientiﬁc achievements to
advance science and medicine, the ability to motivate and mentor
others, and for continuous scientiﬁc excellence in the endothelin ﬁeld.
Such a purpose is likely to also please the award's name holder. In July
2011 ProfessorMasaki, whonow is 78 years old, accepted the invitation
to serve as Honorary Guest Editor of the Endothelin XII Proceedings, and
in an e-mail to the Guest Editor expressed his emotions related to his
main discovery as follows:




The authors are indebted to Hiromi Yanagisawa, Soichi Miwa,
Yoshitoshi Kasuya, and Suzette Sandin for providing information and
photographs and making it possible to use them in this article.
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